Evocati is an independent sponsor focused on life science tools and services

Evocati Capital is an active independent sponsor that focuses on high-science tools companies with revenue and positive, or approaching positive, cash flow. Based in St. Louis, we partner with founders or closely held companies to scale their business by leveraging our network of LS tools executives and deep industry knowledge.

Network

We create value by connecting managers to our executive network in the tools space.

The Evocati team is a group of life science tools operators and deal professionals that have experience and connections that managers can leverage for growth. We have executives that externally support companies in providing sales leadership and sales talent acquisition, international expansion consultation, new product introduction advice, technical collaboration referrals, and e-commerce optimization. These advisors link companies to top talent or experienced and reasonable external support to execute growth initiatives.

Inorganic Growth

We create value by sourcing and executing M&A that have synergies with our platforms

Evocati was founded by a deal professional with over a decade of experience in life science tools M&A. Performing the corporate development and strategy function at several leading tools companies, we have connections to the top banks in the tools space and capital sources that understand the profile of these companies. We understand the technologies and customers for each platform and co-develop an inorganic strategy that we execute in support of the business. 

Sector Experience

We can spot value in life science tools markets and partner with management teams to build on the platform

Our team has spent their careers in life science tools at many of the best companies in the industry. We understand the technologies in demand at pharma companies and those that are emerging. We can identify top candidates for platforms and work with management teams to build a strategy for scale. Due to our ties to top industry players, we can successfully plan for exit.

WE INVEST IN

Research reagents and instruments

Bioprocessing equipment and consumables

Outsourced pharma services

Pharma packaging

Synthetic biology

Complex flavors and fragrances